Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Venlafaxine Hydrochloride Sustained-Release Capsules

Approval Number

国药准字H20213455

Company海南合瑞制药股份有限公司

Registration Date

June 8, 2021

Drug Information

Generic Name

盐酸文拉法辛缓释胶囊

Brand Name

舒乐汀

Dosage Form

胶囊剂

Strength

75mg（按C17H27NO2计）

Drug Type

化学药品

Registration Date

June 8, 2021

Company Information

Applicant Company

Company Name海南合瑞制药股份有限公司

Company Address

海口国家高新区药谷工业园二期内

Manufacturing Company

Company Name海南合瑞制药股份有限公司

Company Address

海口国家高新区药谷工业园二期内

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy